SCHEMBL4974465

SCHEMBL4974465

CC[N+](C)(CC)C1Cc2cc(OC)cc(-c3ccccc3Cl)c2O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.37
CHRM5 P08912 1/20 0.34
DPP4 P27487 2/20 0.34
ALDH1A1 P00352 3/20 0.34
NPC1 O15118 2/20 0.34
MAPT P10636 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
ALOX12 P18054 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TSHR P16473 1/20 0.34
LMNA P02545 1/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
MEN1 O00255 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4967601 0.84 AQP1 (0.47)
SCHEMBL4595488 0.80 MAPK14 (0.42) MAPK14DPP4ALDH1A1NPC1MAPT
SCHEMBL4595485 0.79 MAPK14 (0.41) MAPK14CHRM5DPP4ALDH1A1NPC1
SCHEMBL4225377 0.78 AQP1 (0.52) MAPK14CHRM5DPP4TSHRLMNA
SCHEMBL5605796 0.77 MAPK14 (0.40) MAPK14DPP4ALDH1A1NPC1MAPT
SCHEMBL4226421 0.76 AQP1 (0.56) MAPK14ALDH1A1NPC1MAPTRAB9A
SCHEMBL4226424 0.76 AQP1 (0.42) MAPK14CHRM5DPP4TSHRLMNA
SCHEMBL4791163 0.76 AQP1 (0.36)
SCHEMBL5605793 0.75 MAPK14 (0.41) MAPK14DPP4ALDH1A1NPC1MAPT
SCHEMBL5140813 0.74 AQP1 (0.43) MAPK14ALDH1A1NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1898895-A2 TREATMENT OF DRUG ABUSE Wyeth (US) 2008-03-19 EP disclosed
WO-2006116148-A2 (7-ARLYSUBSTITUTED 2, 3-DIHYDR0-1-BENZ0FURAN-2-YL) ALKYLAMINES IN THE TREATMENT' OF SUBSTANCE ABUSE WYETH (US) 2006-11-02 WO disclosed